Does Baseline Platelet Count Determine the Starting Dose of Ruxolitinib for HU-Refractory/Intolerant PV (Like It Does for MF)?
Dr. Ruben Mesa, Mayo Clinic, answers the following question: Does baseline platelet count determine the starting dose of ruxolitinib for HU-refractory/intolerant PV (like it does for MF)?
Recent Video
Most Popular
Specialties :                    Search :


MPNUniversity.tv is a member of the Oncology.TV family of oncology medical education websites. MPNUniversity.tv offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).